✦ LIBER ✦
Preclinical and clinical studies of estrogen deprivation support the PDGF/Abl pathway as a novel therapeutic target for overcoming endocrine resistance in breast cancer
✍ Scribed by Marion T Weigel, Zara Ghazoui, Anita Dunbier, Sunil Pancholi, Mitch Dowsett, Lesley-Ann Martin
- Book ID
- 118726909
- Publisher
- BioMed Central
- Year
- 2012
- Tongue
- English
- Weight
- 710 KB
- Volume
- 14
- Category
- Article
- ISSN
- 1465-5411
- DOI
- 10.1186/bcr3191
No coin nor oath required. For personal study only.